BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imseeh G, Giles SL, Taylor A, Brown MRD, Rivens I, Gordon-Williams R, Ter Haar G, deSouza NM. Feasibility of palliating recurrent gynecological tumors with MRGHIFU: comparison of symptom, quality-of-life, and imaging response in intra and extra-pelvic disease. Int J Hyperthermia 2021;38:623-32. [PMID: 33882792 DOI: 10.1080/02656736.2021.1904154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fournier L, de Geus-Oei LF, Regge D, Oprea-Lager DE, D'Anastasi M, Bidaut L, Bäuerle T, Lopci E, Cappello G, Lecouvet F, Mayerhoefer M, Kunz WG, Verhoeff JJC, Caruso D, Smits M, Hoffmann RT, Gourtsoyianni S, Beets-Tan R, Neri E, deSouza NM, Deroose CM, Caramella C. Twenty Years On: RECIST as a Biomarker of Response in Solid Tumours an EORTC Imaging Group - ESOI Joint Paper. Front Oncol 2021;11:800547. [PMID: 35083155 DOI: 10.3389/fonc.2021.800547] [Reference Citation Analysis]
2 Lam NFD, Rivens I, Giles SL, Harris E, deSouza NM, Ter Haar G. Quantitative prediction of the extent of pelvic tumour ablation by magnetic resonance-guided high intensity focused ultrasound. Int J Hyperthermia 2021;38:1111-25. [PMID: 34325608 DOI: 10.1080/02656736.2021.1959658] [Reference Citation Analysis]